Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 07 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-2.30 Insider Own8.68% Shs Outstand36.59M Perf Week7.49%
Market Cap2.15B Forward P/E- EPS next Y-0.99 Insider Trans0.00% Shs Float32.79M Perf Month-15.31%
Income-76.69M PEG- EPS next Q-0.21 Inst Own81.41% Short Float / Ratio8.13% / 2.80 Perf Quarter113.25%
Sales0.00M P/S- EPS this Y83.56% Inst Trans- Short Interest2.66M Perf Half Y76.32%
Book/sh5.37 P/B11.14 EPS next Y-14.74% ROA- Target Price89.17 Perf Year-
Cash/sh5.72 P/C10.46 EPS next 5Y- ROE- 52W Range20.80 - 75.02 Perf YTD130.23%
Dividend- P/FCF- EPS past 5Y- ROI-39.13% 52W High-20.20% Beta-
Dividend %- Quick Ratio10.45 Sales past 5Y0.00% Gross Margin- 52W Low187.79% ATR4.17
Employees68 Current Ratio10.45 Sales Q/Q- Oper. Margin0.00% RSI (14)53.56 Volatility6.57% 8.63%
OptionableYes Debt/Eq0.02 EPS Q/Q-48.11% Profit Margin- Rel Volume0.41 Prev Close60.73
ShortableYes LT Debt/Eq0.02 EarningsNov 14 AMC Payout- Avg Volume951.27K Price59.86
Recom1.00 SMA208.00% SMA50-0.14% SMA20063.96% Volume391,546 Change-1.43%
Date Action Analyst Rating Change Price Target Change
Oct-19-23Initiated JMP Securities Mkt Outperform $90
Jul-27-23Initiated Piper Sandler Overweight $58
May-25-23Resumed Jefferies Buy $34 → $41
Feb-28-23Initiated SVB Securities Outperform $33
Feb-28-23Initiated Jefferies Buy $34
Feb-28-23Initiated Guggenheim Buy $50
Feb-28-23Initiated BMO Capital Markets Outperform $40
Nov-29-23 02:28PM
Nov-27-23 09:50AM
Nov-26-23 04:44PM
Nov-14-23 04:10PM
05:20AM Loading…
Nov-03-23 05:20AM
Oct-19-23 08:45AM
Oct-06-23 08:45AM
Oct-02-23 03:48PM
Sep-29-23 04:04PM
07:30AM Loading…
Aug-10-23 04:05PM
Aug-03-23 05:32PM
Jul-16-23 07:00AM
Jun-27-23 02:10PM
Jun-26-23 09:05PM
Jun-16-23 08:00AM
Jun-13-23 06:10AM
Jun-12-23 10:15AM
Jun-07-23 08:30AM
May-31-23 04:30PM
May-25-23 04:30PM
May-18-23 04:30PM
04:30PM Loading…
May-11-23 04:30PM
May-03-23 06:59AM
Mar-30-23 04:30PM
Feb-07-23 04:00PM
Feb-06-23 03:17PM
Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company engaged in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. The company was founded by Raymond Stevens in February 2019 and is headquartered in San Francisco, CA.